Dr. James Dahlman

Biography

James Dahlman is an Associate Professor in the Coulter Department of Biomedical Engineering at Georgia Institute of Technology. His research lies at the interface of chemistry, nanotechnology, and genomics, focusing on developing targeted drug delivery systems and advancing in vivo gene editing techniques using Cas9 and siRNA therapies. He has pioneered the use of DNA barcoded nanoparticles, enabling the simultaneous analysis of over 200 nanoparticles in vivo for therapeutic applications. His lab is dedicated to the innovation of biomaterial design using big data technologies in nanomedicine. Dahlman's work has been recognized in prominent publications such as Science, Nature Nanotechnology, and Cell, and he was honored as one of the 35 innovators under the age of 35 by MIT Technology Review in 2018. His lab emphasizes building an interdisciplinary team comprised of students from diverse scientific backgrounds including medicinal chemistry, bioengineering, and biochemistry. Dahlman is committed to fostering an environment where students can independently generate and test new ideas, especially in the field of drug delivery for treating diseases like cancer and heart disease involving multi-gene therapies.

Research Interests

Experience